4//SEC Filing
GAILEY JOHN R 4
Accession 0001225208-13-012845
CIK 0000105770other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 2:56 PM ET
Size
9.3 KB
Accession
0001225208-13-012845
Insider Transaction Report
Form 4
GAILEY JOHN R
VP, Gen. Counsel & Sec.
Transactions
- Exercise/Conversion
Common Stock
2013-05-20$32.59/sh+9,282$302,454→ 36,797.197 total - Sale
Common Stock
2013-05-20$68.54/sh−9,282$636,189→ 27,515.197 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-05-20$32.59/sh−9,282$302,454→ 0 totalExercise: $32.59From: 2007-02-24Exp: 2016-02-24→ Common Stock (9,282 underlying)
Holdings
- 9,995.582(indirect: Non-Qualified Deferred Compensation Plan)
Common Stock
- 722.401(indirect: By Savings Plan)
Common Stock
Footnotes (1)
- [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001205322
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 2:56 PM ET
- Size
- 9.3 KB